Skip to main content
Loading

Developability of bispecific and multispecific antibodies: Challenges and Solutions

03 Nov 2026
Bi/Multispecifics
  • Which developability assays are most informative for assessing candidates early on? -for stability, PK, high-concentration, immunogenicity, specificity, etc
  • What are the most impactful in silico methods, and how reliable are they?
  • What is the impact of various bispecific/multispecific antibody formats on developability and manufacturability?
  • How does the assessment of bispecific/multispecific antibodies differ from mAbs when interpreting developability assay results?
Industry Expert
Joel Goldstein, Senior Director R&D - Celldex Therapeutics